An online submission and tracking service via internet facilitates a speedy and cost-effective submission of manuscripts. The full manuscript should be submitted online via Bentham's Content Management System (CMS) at bsp-cms.eurekaselect.com / View Submission Instructions.
Manuscripts must be submitted by one of the authors of the manuscript, and should not be submitted by anyone on their behalf. The principal/corresponding author will be required to submit a Copyright Letter along with the manuscript, on behalf of all the co-authors (if any) to confirm that the manuscript (or any part of it) has not been published previously or is not under consideration for publication elsewhere. Furthermore, any illustration, structure or table that has been published elsewhere must be reported, and copyright permission for reproduction must be obtained. The figures from patent documents are freely available on the databases and may not require any permission unless stated otherwise.
For all online submissions, please provide soft copies of all the materials (main text in MS Word or Tex/LaTeX), figures / illustrations in TIFF, PDF or JPEG, and chemical structures drawn in ChemDraw (CDX) / ISISDraw (TGF) as separate files, while a PDF version of the entire manuscript must also be included, embedded with all the figures/illustrations/tables/chemical structures etc.
It is imperative that before submission, the author(s) should carefully proofread the files for special characters, mathematical symbols, Greek letters, equations, tables, references and images to ensure that they appear in proper format.
References, figures, tables, chemical structures, etc. should be referred to in the text at the appropriate places where they have been first discussed. Figure legends / captions should also be provided.
A successful electronic submission of the manuscript will be confirmed by a system-generated email acknowledgement to the principal/corresponding author immediately. Any queries therein should be addressed at email@example.com
The editorial policies of Bentham Science Publishers on publication ethics, peer-review, plagiarism, copyrights/licenses, errata/corrections and article retraction/ withdrawal can be viewed at Editorial Policy
The journal publishes peer-reviewed mini- and full-length review and research articles, and drug clinical trial studies written in English. Single Topic/Thematic Issues by invited Guest Editors are also considered for publication.
For the submission of research articles, the author should have already filed a patent with a leading patent authority and it should be registered. Secondly the author should not have published any research paper on the intellectual property of that patent.
These special issues are peer-reviewed and may contain invited or uninvited review/mini-review articles or a mixture of research articles and reviews/ mini-reviews. A Single Topic Issue Editor will offer a short perspective and co-ordinate the solicitation of manuscripts between 3-5 (for a mini-Thematic Issues) to 6-10 (for full-length Thematic Issues) from leading scientists. Authors interested in editing a single topic issue in an emerging topic of CNS drug discovery may submit their proposal at firstname.lastname@example.org or email@example.com for consideration.
For proposals to publish conference proceedings in this journal, please contact us at email: firstname.lastname@example.org for consideration
A separate section of important and recent patents on CNS drug discovery is also included in the journal. The patents annotated in this section are relevant to the articles published in this journal issue, categorized by therapeutic areas/targets and therapeutic agents related to CNS drug discovery.
Mini-reviews should be 3000-6000 words excluding figures, structures, photographs, schemes, tables etc.
Full-length reviews should be 8000-40000 words excluding figures, structures, photographs, schemes, tables etc.
Research articles should be 4000-8000 words excluding figures, structures, photographs, schemes, tables etc.
The manuscript should be written in English in a clear, direct and active style. All pages must be numbered sequentially, facilitating in the reviewing and editing of the manuscript. For further convenience, our contracted service provider Eureka Science can provide assistance to authors for the preparation of manuscripts.
Manuscripts for review articles submitted to the journal may be divided into the following sections:
It is mandatory to submit a signed copyright letter along with the manuscript, by the author to whom correspondence is to be addressed, delineating the scope of the submitted article declaring the potential competing interests, acknowledging contributions from authors and funding agencies, and certifying that the paper is prepared according to the 'Instructions for Authors'. All inconsistencies in the text and in the reference section and any typographical errors must be carefully checked and corrected before the submission of the manuscript. The article should not contain any material or information that may be unlawful, defamatory, fabricated, plagiarized, or which would, if published, in any way whatsoever, violate the terms and conditions as laid down in the copyright agreement. The authors should acknowledge that the publishers have the legal right to take appropriate action against the authors for any such violation of the terms and conditions as laid down in the copyright agreement. To download the copyright letter, please visit: Download the Copyright letter
The title of the article should be precise and brief and must not be more than 120 characters. Authors should avoid the use of non-standard abbreviations. The title must be written in title case except for articles, conjunctions and prepositions.
Authors must provide a short ‘running title’ of their manuscript.
The names of the authors should be provided according to the previous citations or as the authors would want them to be published along with the institutional affiliations, current address, telephone, cell & fax numbers and the email address. Email address must be provided with an asterisk in front of the name of the principal author. The corresponding author should also be designated and the full address, telephone, cell & fax numbers and the email address must be stated to receive correspondence and galley proofs.
The abstract of an article should be its clear, concise and accurate summary, having no more than 250 words, and including the explicit sub-headings (as in-line or run-in headings in bold). Use of abbreviations should be avoided and the references should not be cited in the abstract. Ideally, each abstract should include the following sub-headings, but these may vary according to requirements of the article.
A graphic should be included when possible with each manuscript for use in the Table of Contents (TOC). This must be submitted separately as an electronic file (preferred file types are EPS, PDF, TIFF, Microsoft Word, PowerPoint and CDX etc.). A graphical abstract, not exceeding 30 words along with the illustration, helps to summarize the contents of the manuscript in a concise pictorial form. It is meant as an aid for the rapid viewing of the journals' contents and to help capture the readers’ attention. The graphical abstract may feature a key structure, reaction, equation, etc. that the manuscript elucidates upon. It will be listed along with the manuscript title, authors’ names and affiliations in the contents page, typeset within an area of 5 cm by 17 cm, but it will not appear in the article PDF file or in print.
Graphical Abstracts should be submitted as a separate file (must clearly mention graphical abstract within the file) online via Bentham's Content Management System by selecting the option “supplementary material”.
6 to 8 keywords must be provided.
The main text should begin on a separate page and should be divided into title page, abstract and the main text. The text may be subdivided further according to the areas to be discussed, which should be followed by the Acknowledgement and Reference sections. The Review Article should mention any previous important, recent and old reviews in the field and contain a comprehensive discussion starting with the general background of the field. It should then go on to discuss the salient features of recent developments along with relevant patents. The authors should avoid presenting material which has already been published in a previous review. The authors are advised to present and discuss their observations in brief. The manuscript style must be uniform throughout the text and 10pt Times New Roman fonts should be used. The full term for an abbreviation should precede its first appearance in the text unless it is a standard unit of measurement. Italics should be used for Binomial names of organisms (Genus and Species), for emphasis and for unfamiliar words or phrases. Non-assimilated words from Latin or other languages should also be italicized e.g. per se, et al., in vitro, in vivo, in situ, etc.
For Research Articles, the manuscript should begin with the title page and abstract followed by the main text, which must be structured into separate sections as Introduction, Material and Methods, Results, Discussion, Conclusion, Current & Future Developments, Conflict of Interest, Acknowledgements and References. If your research article reports the results of a controlled health care intervention such as a Drug Clinical Trial Studies/Case Report, list your trial registry, along with the unique identifying number. The patent registration number and patent authority of the author's intellectual property must be cited in the article.
All clinical investigations must be conducted according to the Declaration of Helsinki principles. For all manuscripts reporting data from studies involving human participants, formal review and approval by an appropriate institutional review board or ethics committee is required. For research involving animals, the authors should indicate whether the procedures followed were in accordance with the standards set forth in the eighth edition of Guide for the Care and Use of Laboratory Animals (grants.nih.gov/grants/olaw/guide-for-the-care-and-use-of-laboratory-animals_prepub.pdf; published by the National Academy of Sciences, The National Academies Press, Washington, D.C.).
A specific declaration of such approval must be made in the copyright letter and in a stand-alone paragraph at the end of the Methods section especially in the case of human studies where inclusion of a statement regarding obtaining the written informed consent from each subject or subject's guardian is a must. The original should be retained by the guarantor or corresponding author. Editors may request to provide the original forms by fax or email.
Randomized drug clinical trial studies are biomedical or health-related interventional and/or observational research studies conducted in phases in human beings who are randomly allocated to receive or not receive a preventive, therapeutic, or diagnostic intervention that follows a pre-defined protocol. The study is intended to determine the safety and efficacy of approaches to disease prevention, diagnosis and treatment.
Authors of randomized controlled trials are encouraged to submit trial protocols along with their manuscripts. All clinical trials must be registered (before recruitment of the first participant) at an appropriate online public trial registry that must be independent of for-profit interest (e.g.,www.clinicaltrials.gov). If you wish the editor(s) to consider an unregistered trial, please explain briefly why the trial has not been registered.
Important points to remember while submitting clinical trials:
The editors reserve the right to reject manuscripts that do not comply with the above-mentioned requirements. The author will be held responsible for false statements or failure to fulfill the above-mentioned requirements.
Authors should review the most recent and important patents based on the topic covered. Coverage of novel bioactive compounds, analogs & targets, techniques and drug design in all areas of CNS drug discovery should be emphasized, including the significance of reported patents.
The review / research article should conclude with a short section called “Current & Future Developments”. The author(s) will give their opinion on the current and future important developments on the topic discussed in their article.
Greek symbols and special characters often undergo formatting changes and get corrupted or lost during preparation of a manuscript for publication. To ensure that all special characters used are embedded in the text, these special characters should be inserted as a symbol but should not be a result of any format styling (Symbol font face) otherwise they will be lost during the conversion to PDF/XML.
Authors are encouraged to consult reporting guidelines. These guidelines provide a set of recommendations comprising a list of items relevant to their specific research design.
Only ISO symbols, written in italic, should be used for the various parameters. All kinds of measurements should be reported only in International System of Units (SI). SI units should always be written in Roman and separated from the numerical value by a space (whatever the language).
The µ in µg or µm should be in Roman. The symbol for litre is L and that for minute is min. For temperature, please use only one of °C, °F or K in the entire manuscript. As the Angström (1Å = 10-10 m) is not an SI unit, it should be replaced by the nanometre (1nm = 10-9 m) or by the picometer (1pm = 10-12 m): 1Å = 0.1nm = 100 pm. Multiple units should be written with negative superscripts (for example, 25mgµL-1 µs-1). The list of notations should appear just before the first paragraph of full text.
A list of symbols and units should be provided if used extensively throughout the text.
A small paragraph summarizing the contents of the article, presenting the final outcome of the research or proposing further study on the subject, may be given at the end of the article under the Conclusion section.
If abbreviations are used in the text either they should be defined in the text where first used, or a list of abbreviations can be provided.
Financial contributions and any potential conflict of interest must be clearly acknowledged under the heading ‘Conflict of Interest’. Authors must list the source(s) of funding for the study. This should be done for each author.
All individuals listed as authors must have contributed substantially to the design, performance, analysis, or reporting of the work and are required to indicate their specific contribution. Anyone (individual/company/institution) who has substantially contributed to the study for important intellectual content, or who was involved in the article’s drafting the manuscript or revising must also be acknowledged.
Guest or honorary authorship based solely on position (e.g. research supervisor, departmental head) is discouraged.
The specific requirements for authorship have been defined by the International Committee of Medical Journal Editors http://www.icmje.org. Examples of authors' contributions are: 'designed research/study', 'performed research/study', 'contributed important reagents', 'collected data', 'analyzed data', 'wrote paper' etc. This information must be included in the submitted manuscript as a separate paragraph under the heading ‘Acknowledgements’. The corresponding author is responsible for obtaining permission from all co-authors for the submission of any version of the manuscript and for any changes in the authorship.
References should be numbered sequentially [in square brackets] in the text and listed in the same numerical order in the reference section. All references must be complete and accurate. Online citations should include the date of access. Journal titles should conform to the present Index Medicus abbreviations. It is necessary to list all authors if the total number of authors is 6 or less and for more than 6 authors use 6 authors and then et al. The reference numbers must be finalized and the bibliography must be fully formatted before submission.
References should be listed in the following Vancouver Style:
Some important points to remember:
All authors must strictly follow the guidelines below for preparing illustrations for publication in Recent Patents on CNS Drug Discovery. If the figures are found to be sub-standard, then the manuscripts will be rejected and the authors offered the option of figure improvement professionally by Eureka Science. The costs for such improvement will be charged to the authors.
Illustrations should be provided as separate files, embedded in the text file, and must be numbered consecutively in the order of their appearance. Each figure should include only a single illustration which should be cropped to minimize the amount of space occupied by the illustration.
If a figure is in separate parts, all parts of the figure must be provided in a single composite illustration file.
Line Art image type is normally an image based on lines and text. It does not contain tonal or shaded areas. The preferred file format should be TIFF or EPS, with the color mode being Monochrome 1-bit or RGB, in a resolution of 900-1200 dpi.
Halftone image type is a continuous tone photograph containing no text. It should have the preferred file format TIFF, with color mode being RGB or Grayscale, in a resolution of 300 dpi.
Combination image type is an image containing halftone, text or line art elements. It should have the preferred file format TIFF, with color mode being RGB or Grayscale, in a resolution of 500-900 dpi.
Illustrations may be submitted in the following file formats:
Bentham Science does not process figures submitted in GIF format.
For TIFF or EPS figures with considerably large file size restricting the file size in online submissions is advisable. Authors may therefore convert to JPEG format before submission as this results in significantly reduced file size and upload time, while retaining acceptable quality. JPEG is a ‘lossy’ format. However, in order to maintain acceptable image quality, it is recommended that JPEG files are saved at High or Maximum quality.
Zipit or Stuffit tools should not be used to compress files prior to submission as the resulting compression through these tools is always negligible.
Please refrain from supplying:
There are many software packages, many of them freeware or shareware, capable of converting to and from different graphics formats, including PNG.
General tools for image conversion include Graphic Converter on the Macintosh, Paint Shop Pro, for Windows, and ImageMagick, available on Macintosh, Windows and UNIX platforms.
Bitmap images (e.g. screenshots) should not be converted to EPS as they result in a much larger file size than the equivalent JPEG, TIFF, PNG or BMP, and poor quality. EPS should only be used for images produced by vector-drawing applications such as Adobe Illustrator or CorelDraw. Most vector-drawing applications can be saved in, or exported as, EPS format. If the images were originally prepared in an Office application, such as Word or PowerPoint, original Office files should be directly uploaded to the site, instead of being converted to JPEG or another format of low quality.
Chemical structures MUST be prepared in ChemDraw (CDX) and provided as separate file.
[As according to the ACS style sheet]
|Bond spacing||18% of width|
|Fixed length||14.4 pt (0.500cm, 0.2in)|
|Bold width||2.0 pt (0.071cm, 0.0278in)|
|Line width||0.6 pt (0.021cm, 0.0084in)|
|Margin width||1.6 pt (0.096cm)|
|Hash spacing||2.5 pt (0.088cm, 0.0347in)|
|Font||Times New Roman|
|Under the Preference Choose:|
|Under Page Setup Use:|
We do encourage to append supportive material, for example a PowerPoint file containing a talk about the study, a PowerPoint file containing additional screenshots, a Word, RTF, or PDF document showing the original instrument(s) used, a video, or the original data (SAS/SPSS files, Excel files, Access Db files etc.) provided it is inevitable or endorsed by the journal's Editor.
Supportive/Supplementary material intended for publication must be numbered and referred to in the manuscript but should not be a part of the submitted paper. In-text citations as well as a section with the heading "Supportive/Supplementary Material" before the "References" section should be provided. Here, all Supportive/Supplementary Material should be listed a brief caption line for each file describing its contents must be included.
Any additional files will be linked to the final published article in the form supplied by the author, but will not be displayed within the paper. They will be made available in exactly the same form as originally provided only on our website. Please also make sure that each additional file is a single table, figure or movie (please do not upload linked worksheets or PDF files larger than one sheet). Supportive/Supplementary material must be provided in a single zipped file not larger than 4 MB.
Authors must clearly indicate if these files are not for publication but meant for the reviewers'/editors' perusal only.
Bentham Science has collaborated with the Copyright Clearance Center to meet our customer’s licensing, besides rights & permission needs.
The Copyright Clearance Center’s RightsLink® service makes it faster and easier to secure permission from Bentham Science’s journal titles. Simply visit Journals by Title and locate the desired content. Then go to the article’s abstract and click on “Rights and Permissions” to open the RightsLink’s page. If you are unable to locate the content you wish to use or you are unable to secure the rights you are seeking, please e-mail us at email@example.com
Published/reproduced material should not be included unless written permission has been obtained from the copyright holder, which should be forwarded to the Editorial Office in case of acceptance of the article for publication.
All papers submitted for publication are immediately subjected to editorial scrutiny, usually in consultation with members of the journal Editorial Advisory Board and outside independent reviewers. Every effort will be made to peer review submitted papers quickly. Papers which are delayed by authors in revision for more than 30 days will have to be re-submitted as a new submission. Papers accepted for publication are typeset and proofs are dispatched to authors for any corrections prior to final publication.
No page charges will be levied to the authors.
Manuscripts submitted containing language inconsistencies will not be published. Authors must seek professional assistance for correction of grammatical, scientific and typographical errors. Professional team available at Eureka Science may assist you in the English language editing of your article. Please contact Eureka Science for a language editing quote at e-mail: firstname.lastname@example.org stating the total number of words of the article to be edited.
영문 오타가 많은 원고는 출판되지 않을 것입니다. 영문 오타를 없애겠다는 조건으로 받은 원고는 영어 편집 전문회사인 유럽 공동 기술개발 기구로부터 가격 견적서가 보내 질 것입니다. 영어 작문에 어려움이 있는 비영어권 국가의 저자들은 원고를 학술지에 제출하기 전에 영어 편집회사와 접촉할 것을 권합니다. 영어 편집 견적서를 받기 위해서 교정될 원고의 단어수를 적은 메일을 유럽 공동 기술개발 기구 메일인 email@example.com 로 보내시기 바랍니다.
Les manuscrits soumis avec plusieurs erreurs typographiques en Anglais ne seront pas publiés en l’état. Les manuscrits sont acceptés pour publication à la condition que l'anglais utilisé soit corrigé après la soumission et seront envoyés pour examen à Eureka Science, une société d'édition de langue professionnelle. Les auteurs en provenance de pays où la langue est différente de l'anglais et qui ont de médiocres compétences en anglais écrit, sont priés de contacter la société d'édition de langue avant de soumettre leur manuscrit à la revue. Merci de contacter Eureka Science à Eureka Science à firstname.lastname@example.org pour un devis en indiquant le nombre total de mot de l’article à éditer.
Authors will receive page proofs of their accepted paper before publications. To avoid delays in publication, proofs should be checked immediately for typographical errors and returned within 48 hours. Major changes are not acceptable at the proof stage. If unable to send corrections within 48 hours due to some reason, the author(s) must at least send an acknowledgement on receiving the galley proofs or the article will be published exactly as received and the publishers will not be responsible for any error occurring in the published manuscript in this regard.
The corresponding author will be solely responsible for ensuring that the revised version of the manuscript incorporating all the submitted corrections receives the approval of all the co-authors of the manuscript.
Printed reprints may be ordered from the Publisher prior to publication of the article. First named authors may also order a personal print and online subscription of the journal at 50% off the normal subscription rate by contacting the subscription department at e-mail: email@example.com.
Bentham Science also offers authors the choice of “Open Access Plus” publication of articles at a fee of US$ 890 per article. This paid service allows for articles to be disseminated to a much wider audience, on the terms of the Creative Commons CC BY-NC-ND (Attribution-NonCommercial-NoDerivs) Licence (http://creativecommons.org/licenses/by-nc-nd/4.0/). Authors are asked to indicate whether or not they wish to pay to have their article made more widely available on this “Open Access Plus” basis. Where an author does not opt-in to this paid service, then the author’s article will be published only on Bentham Science’s standard subscription-based access, at no additional cost to the author.
For more information please contact us at e-mail: firstname.lastname@example.org
Authors who publish in Bentham Science Journals will transfer copyright to their work to Bentham Science Publishers. Submission of a manuscript to the respective journals implies that all authors have read and agreed to the content of the Copyright Letter or the Terms and Conditions. It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere. Plagiarism is strictly forbidden, and by submitting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism or fabricated information is discovered. By submitting a manuscript the authors agree that the copyright of their article is transferred to the publishers if and when the article is accepted for publication. Once submitted to the journal, the author will not withdraw their manuscript at any stage prior to publication.
By signing the Copyright Letter the authors retain the rights of self-archiving. Following are the important features of self-archiving policy of Bentham Science journals:
Bentham Science Publishers uses the iThenticate software to detect instances of overlapping and similar text in submitted manuscripts. iThenticate software checks content against a database of periodicals, the Internet, and a comprehensive article database. It generates a similarity report, highlighting the percentage overlap between the uploaded article and the published material. Any instance of content overlap is further scrutinized for suspected plagiarism according to the publisher’s Editorial Policies. Bentham Science allows an overall similarity of 20% for a manuscript to be considered for publication. The similarity percentage is further checked keeping the following important points in view:
The text of every submitted manuscript is checked using the Content Tracking mode in iThenticate. The Content Tracking mode ensures that manuscripts with an overall low percentage similarity (but which may have a higher similarity from a single source) are not overlooked. The acceptable limit for similarity of text from a single source is 5%. If the similarity level is above 5%, the manuscript is returned to the author for paraphrasing the text and citing the original source of the copied material.
It is important to mention that the text taken from different sources with an overall low similarity percentage will be considered as a plagiarized content if the majority of the article is a combination of copied material.
There may be some manuscripts with an overall low similarity percentage, but a higher percentage from a single source. A manuscript may have less than 20% overall similarity but there may be 15 % similar text taken from a single article. The similarity index in such cases is higher than the approved limit for a single source. Authors are advised to thoroughly rephrase the similar text and properly cite the original source to avoid plagiarism and copyright violation.
We all know that scholarly manuscripts are written after thorough review of previously published articles. It is therefore not easy to draw a clear boundary between legitimate representation and plagiarism. However, the following important features can assist in identifying different kinds of plagiarized content. These are:
Published manuscripts which are found to contain plagiarized text are retracted from the journal website after careful investigation and approval by the Editor-in-Chief of the journal. A ‘Retraction Note’ as well as a link to the original article is published on the electronic version of the plagiarized manuscript and an addendum with retraction notification in the journal concerned.
Bentham Science Publishers are pleased to offer electronic publication of accepted papers prior to scheduled publication. These peer-reviewed papers can be cited using the date of access and the unique DOI number. Any final changes in manuscripts will be made at the time of print publication and will be reflected in the final electronic version of the issue. Articles ahead of schedule may be ordered by pay-per-view at the relevant links by each article stated via the E-Pub Ahead of Schedule
Responsibility for the content published by Bentham Science Publishers (BSP) in any of its journals, including any opinions expressed therein, rests exclusively with the author(s) of such content. To the maximum extent permitted by applicable law, BSP (on its own behalf, and on behalf of its staff and members of its editorial board) disclaims responsibility for any and all injury and/or damage (whether financial or otherwise) to persons or property, resulting directly or indirectly from any ideas, methods, instructions or products (including errors in the same) referred to in the content of any of BSP’s journals. Any dispute arising, including any claim, shall be governed exclusively by the laws of the United Arab Emirates, as applied in the Emirate of Sharjah.